Point72 Asset Management’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Hold |
0
| – | – | – | 1659 |
|
2025
Q1 | – | Hold |
0
| – | – | – | 1621 |
|
2024
Q2 | – | Sell |
-28,033
| Closed | -$1.43M | – | 1592 |
|
2024
Q1 | $1.43M | Buy |
+28,033
| New | +$1.43M | ﹤0.01% | 903 |
|
2023
Q4 | – | Sell |
-6,834
| Closed | -$108K | – | 1843 |
|
2023
Q3 | $108K | Hold |
6,834
| – | – | ﹤0.01% | 1283 |
|
2023
Q2 | $113K | Hold |
6,834
| – | – | ﹤0.01% | 1011 |
|
2023
Q1 | $95.7K | Hold |
6,834
| – | – | ﹤0.01% | 1151 |
|
2022
Q4 | $69.6K | Sell |
6,834
-96,377
| -93% | -$981K | ﹤0.01% | 938 |
|
2022
Q3 | $1.32M | Buy |
103,211
+31,340
| +44% | +$401K | 0.01% | 820 |
|
2022
Q2 | $1.48M | Buy |
71,871
+10,621
| +17% | +$219K | 0.01% | 797 |
|
2022
Q1 | $2.3M | Buy |
61,250
+10,710
| +21% | +$403K | 0.01% | 776 |
|
2021
Q4 | $4.87M | Buy |
50,540
+540
| +1% | +$52.1K | 0.02% | 641 |
|
2021
Q3 | $7.23M | Buy |
50,000
+5,845
| +13% | +$845K | 0.03% | 533 |
|
2021
Q2 | $8.15M | Sell |
44,155
-21,275
| -33% | -$3.93M | 0.04% | 468 |
|
2021
Q1 | $16.1M | Buy |
65,430
+5,644
| +9% | +$1.39M | 0.08% | 303 |
|
2020
Q4 | $16.9M | Buy |
59,786
+9,801
| +20% | +$2.76M | 0.08% | 300 |
|
2020
Q3 | $12M | Buy |
49,985
+25,435
| +104% | +$6.1M | 0.06% | 354 |
|
2020
Q2 | $8.15M | Sell |
24,550
-5,510
| -18% | -$1.83M | 0.05% | 365 |
|
2020
Q1 | $6.84M | Buy |
30,060
+23,721
| +374% | +$5.4M | 0.06% | 331 |
|
2019
Q4 | $1.56M | Buy |
+6,339
| New | +$1.56M | 0.01% | 613 |
|
2018
Q2 | – | Sell |
-12,505
| Closed | -$3.52M | – | 941 |
|
2018
Q1 | $3.52M | Sell |
12,505
-3,750
| -23% | -$1.06M | 0.01% | 521 |
|
2017
Q4 | $3.82M | Buy |
+16,255
| New | +$3.82M | 0.02% | 524 |
|